Tekla Healthcare Investors chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.17
Dividend & Yield1.65$ (9.18%)
Beta 0.85
Market capitalization 862.6M
Operating cash flow N/A
ESG Scores 26.9

Company description

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Sector: Financial Services - Industry: Asset Management

Financial data

Financial Statements

Cashflow Statement 2019-09-30 2020-09-30 2021-09-30 2022-09-30
Change To Liabilities
Total Cashflows From Investing Activities
Net Borrowings
Total Cash From Financing Activities
Change To Operating Activities
Issuance Of Stock
Net Income -145.29M 241.2M 155.18M -194.23M
Change In Cash
Effect Of Exchange Rate
Total Cash From Operating Activities
Depreciation
Change To Account Receivables
Other Cashflows From Financing Activities
Change To Netincome
Capital Expenditures

Income Statement 2019-09-30 2020-09-30 2021-09-30 2022-09-30
Research Development
Income Before Tax -145.29M 241.2M 155.18M -194.23M
Net Income -145.29M 241.2M 155.18M -194.23M
Selling General Administrative 10.47M 10.9M 12.71M 11.94M
Gross Profit 7.6M 8.93M 6.48M 8.27M
Ebit -2.87M -1.97M -6.23M -3.67M
Operating Income -2.87M -1.97M -6.23M -3.67M
Interest Expense
Income Tax Expense
Total Revenue 7.6M 8.93M 6.48M 8.27M
Cost Of Revenue
Total Other Income ExpenseNet -142.42M 243.18M 161.41M -190.56M
Net Income From Continuing Ops -145.29M 241.2M 155.18M -194.23M
Net Income Applicable To Common Shares -145.29M 241.2M 155.18M -194.23M

Balance Sheet Statement 2019-09-30 2020-09-30 2021-09-30 2022-09-30
Total Liabilities 6.93M 1.12M 15.63M 9.71M
Total Stockholder Equity 870.85M 1.05B 1.16B 916.56M
Other Current Liabilities 26.32k 3.01M
Total Assets 877.78M 1.06B 1.17B 926.28M
Common Stock 796.14M 438.72k 454.25k 473.44k
Other Current Assets 15.93M 2.46M 8.3M 39.79M
Retained Earnings 74.71M 239.52M 303.1M 24.82M
Treasury Stock
Cash 1.65M 935 792
Total Current Liabilities 6.93M 1.09M 15.63M 9.71M
Other Stockholder Equity
Property, Plant, and Equipment
Total Current Assets 27.38M 6.84M 12.4M 42.71M
Net Tangible Assets 870.85M 1.05B 1.16B 916.56M
Net Receivables 9.74M 4.32M 4.05M 2.87M
Accounts Payable 5.97M


Insider Transactions

Here are the insider transactions of stock shares related to Tekla Healthcare Investors:

Filer Name Transaction Text Ownership Date Filer Relation Shares
GOETZ KATHLEENPurchase at price 20.42 per share.D2022-03-23Director74
GOETZ KATHLEENPurchase at price 21.52 per share.D2022-01-26Director481
OMSTEAD DANIEL RPurchase at price 20.53 per share.D2020-10-26President5.2k
OMSTEAD DANIEL RPurchase at price 20.68 per share.D2020-10-21President5.05k
BAILEY JEFFREY ALLENPurchase at price 20.39 per share.D2020-09-23Director490
OMSTEAD DANIEL RPurchase at price 21.01 per share.D2020-05-21President5k
OMSTEAD DANIEL RPurchase at price 16.24 per share.D2020-03-17President6.8k
OMSTEAD DANIEL RPurchase at price 17.14 per share.D2018-12-26President6.3k
OMSTEAD DANIEL RPurchase at price 20.43 per share.D2018-10-25President5.5k
OMSTEAD DANIEL RPurchase at price 21.78 per share.D2018-10-17President3.88k
KENT THOMAS MPurchase at price 24.19 per share.D2018-01-25Director1.1k
GASPERONI TIMOTHY LPurchase at price 28.98 per share.D2016-01-06Divisional Officer862
STEBBINS LUCINDA HPurchase at price 35.74 per share.D2015-06-29Director2k
POHOTSKY OLEG MConversion of Exercise of derivative security at price 25.04 per share.D2014-06-24Director77
REINHARDT UWE EConversion of Exercise of derivative security at price 25.04 per share.D2014-06-24Director745
BONNEY MICHAEL WConversion of Exercise of derivative security at price 25.04 per share.D2014-06-24Director1.1k
OMSTEAD DANIEL RConversion of Exercise of derivative security at price 25.04 per share.D2014-06-24President11.94k
REARDON WILLIAM SConversion of Exercise of derivative security at price 25.04 per share.D2014-06-24Director742
STEBBINS LUCINDA HConversion of Exercise of derivative security at price 25.04 per share.D2014-06-24Director1.4k
OMSTEAD DANIEL RPurchase at price 21.45 per share.D2013-06-04President10k
POHOTSKY OLEG MPurchase at price 16.00 per share.D2012-03-19Director200
BONNEY MICHAEL WPurchase at price 15.80 per share.D2012-03-09Director650
REARDON WILLIAM SPurchase at price 15.86 per share.D2012-03-09Director646
OMSTEAD DANIEL RPurchase at price 12.37 per share.D2011-08-08President8.1k
STEBBINS LUCINDA HPurchase at price 10.50 - 10.52 per share.D2009-09-03Director1k
OMSTEAD DANIEL RPurchase at price 10.70 per share.D2009-08-06President3k
OMSTEAD DANIEL RPurchase at price 8.97 per share.D2008-11-26President2k
OMSTEAD DANIEL RPurchase at price 11.40 per share.D2008-10-10President387
OMSTEAD DANIEL RPurchase at price 15.81 - 15.82 per share.D2007-11-21President1.5k
OMSTEAD DANIEL RPurchase at price 17.40 per share.D2007-10-03President1.5k
STEBBINS LUCINDA HPurchase at price 16.63 per share.D2007-08-21Director1k
OMSTEAD DANIEL RPurchase at price 16.79 per share.D2007-08-03President1k
STEBBINS LUCINDA HPurchase at price 16.41 per share.D2006-12-27Director3k
OMSTEAD DANIEL RPurchase at price 16.30 per share.D2005-04-01President2.7k
OMSTEAD DANIEL RPurchase at price 16.75 - 16.77 per share.D2004-07-29President800
MACK ROBERT PPurchase at price 16.80 per share.D2004-06-28Director1.25k
LEWIN LAWRENCE SPurchase at price 16.80 per share.D2004-06-25Director1.49k
BISNER KERRI ASale at price 25.98 per share.D2001-07-31Former750
REINHARDT UWE EPurchase at price 18.00 per share.D1996-07-16Director500
REINHARDT UWE EPurchase at price 18.00 per share.1996-07-16Director500
BISNER KERRI AConversion of Exercise of derivative security at price 14.38 per share.D1995-03-02Officer100
CARROLL KIMBERLEY LPurchase at price 29.38 per share.I1992-01-09Officer100
CARROLL KIMBERLEY LPurchase at price 22.50 per share.D1991-12-12Officer190

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Tekla Healthcare Investors. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Tekla Healthcare Investors

Here is the result of two systematic investment strategies applied to Tekla Healthcare Investors. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Tekla Healthcare Investors

The following chart shows the equity curve of the two systematic investment strategies applied to Tekla Healthcare Investors:

Tekla Healthcare Investors automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 20.76% on the backtest period.

Performance at glance

Performance

20.76 %

Latent gain

465.78 $

Invested capital

2244.15 $

Annualized return

5.01 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Tekla Healthcare Investors

This is the result of two momentum investment strategies applied to Tekla Healthcare Investors. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Tekla Healthcare Investors

The following chart shows all the entries opened by the momentum investment system on Tekla Healthcare Investors:

Tekla Healthcare Investors momentum entries
  • The first momentum investment strategy would give 26.35% of return on Tekla Healthcare Investors. That represents 1388.11$ of latent gain with 5268.32$ of employed capital.
  • The second momentum investment strategy would give 27.72% of return on Tekla Healthcare Investors. That represents 1045.09$ of latent gain with 3769.64$ of employed capital.
Performance at glance (1Q Momentum)

Performance

26.35 %

Latent gain

1388.11 $

Invested capital

5268.32 $

Annualized return

10.02 %
Performance at glance (2Q Momentum)

Performance

27.72 %

Latent gain

1045.09 $

Invested capital

3769.64 $

Annualized return

7.57 %

Momentum equity curve on Tekla Healthcare Investors

The following chart shows the equity curve of the two momentum strategies applied to Tekla Healthcare Investors:

Tekla Healthcare Investors momentum equity

Note: the dividends potentially given by Tekla Healthcare Investors are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Tekla Healthcare Investors

The following chart shows the employed capital evolution of the two momentum strategies on Tekla Healthcare Investors since the beginning:

Tekla Healthcare Investors

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Tekla Healthcare Investors

Buy the dip entry openings on Tekla Healthcare Investors

Tekla Healthcare Investors

The performance achieved by the robo-advisor on Tekla Healthcare Investors is 21.45%. That represents 213.79$ of latent gain with 996.47$ of employed capital. The following chart shows Tekla Healthcare Investors stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Tekla Healthcare Investors, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

21.45 %

Latent gain

213.79 $

Invested capital

996.47 $

Annualized return

10.02 %

Equity curve of the strategy applied to Tekla Healthcare Investors

The following chart shows the result of the investment strategy applied to Tekla Healthcare Investors:

Tekla Healthcare Investors

Note: the dividends potentially given by Tekla Healthcare Investors are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Tekla Healthcare Investors

The following chart shows the employed capital evolution since the beginning of the investment strategy on Tekla Healthcare Investors:

Tekla Healthcare Investors

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Tekla Healthcare Investors

In this section, I will compare the three previous investment strategies applied to Tekla Healthcare Investors.

Equity curve comparison on Tekla Healthcare Investors

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Tekla Healthcare Investors investment strategy comparison

Employed capital comparison on Tekla Healthcare Investors

Tekla Healthcare Investors investment comparison

Performance comparison on Tekla Healthcare Investors

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 20.76% 465.78$ 2244.15$ 5.01%
Momentum 1 quarter 26.35% 1388.11$ 5268.32$ 6.76%
Momentum 2 quarters 27.72% 1045.09$ 3769.64$ 7.57%
Non-directional 21.45% 213.79$ 996.47$ 10.02%
Annualized return comparison

Automatic investment

5.01 %

Momentum 1Q

7.57 %

Momentum 2Q

7.57 %

Non-directional

10.02 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Tekla Healthcare Investors:

Note: The algorithm computes the probability of correlation between Tekla Healthcare Investors and the other stocks. There may be false positives or some missing correlated stocks. If the price of Tekla Healthcare Investors does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Tekla Healthcare Investors
Country United States
City Boston
Address 100 Federal Street
Phone 617 772 8500
Website www.teklacap.com/hqh.html
FullTime employees
Industry Asset Management
Sector Financial Services
Exchange XNYS
Ticker HQH
Market www.nyse.com

Tekla Healthcare Investors ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0.6
Peer Environment Performance 1.68
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 12.7
Peer Social Performance 12.468
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count yes

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 6.6
Peer Governance Performance 7.008
Governance Percentile unknown

ESG at glance
Total ESG Scores: 26.9
Environment Score: 0.6
Social Score: 12.7
Governance Score: 6.6

ESG Performance: AVG_PERF

Peer Group: US CE Health

Peer Esg Score Performance: 26.298

Rating Year: 2020

Rating Month: 12

Max Age: 86400

Percentile: unknown